Streetbeat News

Products Services

CTLT

LLY

NVO

Novo Nordisk (NVO) and Eli Lilly (LLY) are addressing the supply shortage of their weight loss drugs, Wegovy and Zepbound, amid soaring demand. Novo Nordisk has doubled the availability of Wegovy's lower doses and acquired three manufacturing sites for $11 billion to boost production. Eli Lilly has doubled its production capacity for incretin drugs and plans further expansion. Both companies are exploring alternative drug forms to meet demand, with Eli Lilly launching Mounjaro in a new delivery device outside the U.S. LLY shares slightly up, NVO shares down in premarket trading.

Portfolio Pulse from Vandana Singh

February 12, 2024 | 1:57 pm

ANTX

AN2 Therapeutics announced a voluntary pause in the Phase 3 part of their Phase 2/3 pivotal clinical trial for epetraborole in treatment-refractory MAC lung disease, leading to a decrease in their stock price.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 1:55 pm

WTW

WTW (NASDAQ:WTW) has announced a co-brokerage agreement with the Solomon Agency Corporation to provide brokerage support and customized insurance solutions to North American exposures of companies headquartered in South Korea and Vietnam. This partnership leverages WTW's Asia Risk Division and Solomon Agency's client base, aiming to deliver optimal risk transfer services and solutions in the Asia Pacific region. The collaboration aligns WTW's industry knowledge and market relationships to serve the unique needs of Asian companies in North America.

Portfolio Pulse from Happy Mohamed

February 12, 2024 | 1:52 pm

KO

Coca-Cola (NYSE:KO) is anticipated to release its Q4 earnings on Feb. 13, 2024, with expected earnings of 49 cents per share and revenue of $10.68 billion, up from the previous year. Barclays analyst Lauren Lieberman has maintained an Overweight rating on KO, raising the price target from $60 to $66. Coca-Cola India is entering the ready-to-drink tea market with 'Honest Tea'. The company's dividend yield stands at 3.09%, with a quarterly dividend of 46 cents a share. To earn $500 monthly from dividends, an investor would need approximately 3,261 shares, valued around $194,225.

Portfolio Pulse from Avi Kapoor

February 12, 2024 | 1:52 pm

CBAY

CymaBay Therapeutics announced that the FDA has accepted its New Drug Application (NDA) for Seladelpar, aimed at treating Primary Biliary Cholangitis, and has granted it Priority Review status. The target Prescription Drug User Fee Act (PDUFA) date is set for August 14.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 1:47 pm

AGR

Avangrid's stock price increased following the announcement of a wind energy project in collaboration with Amazon. This partnership highlights Avangrid's expansion in renewable energy and its strategic relationship with major corporations.

Portfolio Pulse from Luke J Jacobi

February 12, 2024 | 1:47 pm

AAPL

Apple Inc.'s (NASDAQ:AAPL) Vision Pro headset has received mixed reviews, with some praising its 'magical' experience and others highlighting issues such as a lack of apps and a high price tag. Critics argue it feels like a prototype, and prolonged use may cause discomfort like 'massive pimples'. Despite these concerns, analysts are optimistic, comparing its launch to the iPhone and predicting significant sales growth.

Portfolio Pulse from Rounak Jain

February 12, 2024 | 1:45 pm

RVSN

Rail Vision has introduced a new AI computer designed to enhance railway safety through high performance and real-time AI deep learning inferencing. This development represents a significant step forward in leveraging technology to improve safety measures in the railway industry.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 1:42 pm

MGRM

Monogram Orthopaedics Inc. (NASDAQ:MGRM) presented its mBôs commercial robot and mVision technology at the AAOS Annual Meeting. The company showcased a recorded discussion with a panel of orthopaedic surgeons discussing the features and potential of these technologies. CEO Ben Sexson will also present at the 2024 Canaccord Genuity Musculoskeletal Conference. The AAOS Annual Meeting is a significant event for orthopaedic professionals globally.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 1:39 pm

SABR

Riyadh Air has chosen Sabre's technology solutions to enhance its Network Planning, Commercial, and Analytics processes. This collaboration positions Riyadh Air for future operations, as it partners with world-class suppliers ahead of its first flight in 2025. Financial terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 1:37 pm